EPS for Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Expected At $1.09, Hydrogenics New (HYGS) Shorts Lowered By 9.1%

July 27, 2017 - By Marie Mckinney

Analysts expect Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) to report $1.09 EPS on August, 3 before the open.They anticipate $0.16 EPS change or 12.80% from last quarter’s $1.25 EPS. TEVA’s profit would be $1.09B giving it 7.57 P/E if the $1.09 EPS is correct. After having $1.03 EPS previously, Teva Pharmaceutical Industries Ltd (ADR)’s analysts see 5.83% EPS growth. About 2,469 shares traded. Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has declined 41.70% since July 27, 2016 and is downtrending. It has underperformed by 58.40% the S&P500.

Hydrogenics Corporation New (NASDAQ:HYGS) had a decrease of 9.1% in short interest. HYGS’s SI was 340,800 shares in July as released by FINRA. Its down 9.1% from 374,900 shares previously. With 196,900 avg volume, 2 days are for Hydrogenics Corporation New (NASDAQ:HYGS)’s short sellers to cover HYGS’s short positions. The SI to Hydrogenics Corporation New’s float is 3.03%. About shares traded. Hydrogenics Corporation (USA) (NASDAQ:HYGS) has risen 1.42% since July 27, 2016 and is uptrending. It has underperformed by 15.28% the S&P500.

Teva Pharmaceutical Industries Limited is a pharmaceutical company. The company has market cap of $33.03 billion. The Firm is engaged in developing, producing and marketing generic medicines and a portfolio of specialty medicines. It has a 312.26 P/E ratio. The Firm operates through two divisions: Generic medicines and Specialty medicines.

Among 26 analysts covering Teva Pharma (NYSE:TEVA), 12 have Buy rating, 0 Sell and 14 Hold. Therefore 46% are positive. Teva Pharma had 70 analyst reports since July 21, 2015 according to SRatingsIntel. The stock has “Buy” rating by Deutsche Bank on Tuesday, July 28. The stock has “Buy” rating by Maxim Group on Wednesday, November 16. The stock of Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has “Outperform” rating given on Wednesday, November 16 by RBC Capital Markets. The stock has “Market Perform” rating by Wells Fargo on Monday, January 9. The stock of Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) earned “Outperform” rating by RBC Capital Markets on Monday, November 14. The rating was maintained by Mizuho on Thursday, August 25 with “Buy”. The stock has “Outperform” rating by Leerink Swann on Tuesday, July 21. The stock of Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has “Overweight” rating given on Wednesday, July 29 by Morgan Stanley. Jefferies maintained Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) on Thursday, June 22 with “Hold” rating. The stock of Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has “Buy” rating given on Wednesday, January 4 by Maxim Group.

Hydrogenics Corp is a Canada-based firm, which creates and makes hydrogen generation products based on water electrolysis technology, and fuel cell products based on proton exchange membrane technology. The company has market cap of $113.12 million. The Company’s divisions are Onsite Generation and Power Systems. It currently has negative earnings. The OnSite Generation segment is based in Oevel, Belgium and develops products for industrial gas, hydrogen fueling and renewable energy storage markets.